308 related articles for article (PubMed ID: 35189473)
1. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
[TBL] [Abstract][Full Text] [Related]
2. Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia.
Yang Z; Abdul Rashid NA; Quek YF; Lam M; See YM; Maniam Y; Dauwels J; Tan BL; Lee J
Schizophr Res; 2018 Sep; 199():58-63. PubMed ID: 29549976
[TBL] [Abstract][Full Text] [Related]
3. Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test (DSST) as a screening tool for evaluation of cognitive deficits in schizophrenia.
Daderwal MC; Sreeraj VS; Suhas S; Rao NP; Venkatasubramanian G
Psychiatry Res; 2022 Oct; 316():114731. PubMed ID: 35926360
[TBL] [Abstract][Full Text] [Related]
4. Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review.
Rosca EC; Cornea A; Simu M
Gen Hosp Psychiatry; 2020; 65():64-73. PubMed ID: 32502879
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of extent and pattern of neurocognitive functions in mild and moderate traumatic brain injury patients by using Montreal Cognitive Assessment (MoCA) score as a screening tool: An observational study from India.
Panwar N; Purohit D; Deo Sinha V; Joshi M
Asian J Psychiatr; 2019 Mar; 41():60-65. PubMed ID: 30396805
[TBL] [Abstract][Full Text] [Related]
6. Utility of the MoCA for cognitive impairment screening in long-term psychosis patients.
Gil-Berrozpe GJ; Sánchez-Torres AM; García de Jalón E; Moreno-Izco L; Fañanás L; Peralta V; Cuesta MJ;
Schizophr Res; 2020 Feb; 216():429-434. PubMed ID: 31801676
[TBL] [Abstract][Full Text] [Related]
7. A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA).
Wu C; Dagg P; Molgat C
Schizophr Res; 2014 Sep; 158(1-3):151-5. PubMed ID: 25092174
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study.
Jia X; Wang Z; Huang F; Su C; Du W; Jiang H; Wang H; Wang J; Wang F; Su W; Xiao H; Wang Y; Zhang B
BMC Psychiatry; 2021 Oct; 21(1):485. PubMed ID: 34607584
[TBL] [Abstract][Full Text] [Related]
9. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
[TBL] [Abstract][Full Text] [Related]
10. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study.
Zuo L; Dong Y; Zhu R; Jin Z; Li Z; Wang Y; Zhao X; Sachdev P; Zhang W; Wang Y
BMJ Open; 2016 Jul; 6(7):e011310. PubMed ID: 27406642
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Telephone Version for the Montreal Cognitive Assessment: Establishing a Cutoff for Normative Data From a Cross-Sectional Study.
Klil-Drori S; Phillips N; Fernandez A; Solomon S; Klil-Drori AJ; Chertkow H
J Geriatr Psychiatry Neurol; 2022 May; 35(3):374-381. PubMed ID: 33858238
[TBL] [Abstract][Full Text] [Related]
12. Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration.
Dujardin K; Duhem S; Guerouaou N; Djelad S; Drumez E; Duhamel A; Bombois S; Nasreddine Z; Bordet R; Deplanque D
Rev Neurol (Paris); 2021 Oct; 177(8):972-979. PubMed ID: 33478740
[TBL] [Abstract][Full Text] [Related]
13. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study.
Yu J; Li J; Huang X
BMC Psychiatry; 2012 Sep; 12():156. PubMed ID: 23009126
[TBL] [Abstract][Full Text] [Related]
14. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
[TBL] [Abstract][Full Text] [Related]
15. Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.
Bezdicek O; Červenková M; Moore TM; Stepankova Georgi H; Sulc Z; Wolk DA; Weintraub DA; Moberg PJ; Jech R; Kopecek M; Roalf DR
Assessment; 2020 Dec; 27(8):1960-1970. PubMed ID: 29929376
[TBL] [Abstract][Full Text] [Related]
16. The Montreal Cognitive Assessment is a valid cognitive screening tool for cardiac arrest survivors.
van Gils P; van Heugten C; Hofmeijer J; Keijzer H; Nutma S; Duits A
Resuscitation; 2022 Mar; 172():130-136. PubMed ID: 34958880
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
Ribeiro M; Durand T; Roussel M; Feuvret L; Jacob J; Psimaras D; Noel G; Keller A; Bompaire F; Hoang-Xuan K; Bernier MO; Godefroy O; Ricard D
J Neurooncol; 2020 Jun; 148(2):335-342. PubMed ID: 32415644
[TBL] [Abstract][Full Text] [Related]
19. Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization.
Wu C; Dagg P; Molgat C
Psychiatry Res; 2017 Dec; 258():299-304. PubMed ID: 28886902
[TBL] [Abstract][Full Text] [Related]
20. Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA.
Belvederi Murri M; Folesani F; Costa S; Biancosino B; Colla C; Zerbinati L; Caruso R; Nanni MG; Purdon SE; Grassi L
Schizophr Res; 2020 Apr; 218():188-194. PubMed ID: 31948897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
